Show simple item record

dc.contributor.authorApaydin, Suheyla
dc.contributor.authorKasapoglu, Umut
dc.contributor.authorAkbay, Fatih Gokhan
dc.contributor.authorKayalar, Arzu Ozdemir
dc.contributor.authorKudu, Aysegul
dc.contributor.authorDikec, Mehmet
dc.contributor.authorDeger, Gunden
dc.contributor.authorToprak, Zeki
dc.contributor.authorCarin, Mahmut Nezih
dc.date.accessioned2020-09-15T07:08:15Z
dc.date.available2020-09-15T07:08:15Z
dc.date.issued2020
dc.identifier.citationAPAYDIN, S., KASAPOGLU, U., AKBAY, F. G., Ozdemir Kayalar, A., KUDU, A., Dikec, M., ... & CARIN, M. (2020). P1787 DESENSITIZATION IN LIVE KIDNEY DONOR RECIPIENTS PROVIDES GOOD OUTCOME AT MID-TERM FOLLOW-UP. Nephrology Dialysis Transplantation, 35(Supplement_3), gfaa142-P1787.en_US
dc.identifier.issn0931-0509
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1020
dc.description.abstractThe recipients who have antibodies againts to donors’ HLA (Anti HLA- DSA) carrie a huge risk for allograf (AG) losing. In current study, it was retrospectively evaluated whether the live donor kidney recipients (LDKRs) under desensitization (DS) were exposed to more AG loss, lower AG survival and more complications.en_US
dc.language.isoengen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleDesensitization in live kidney donor recipients provides good outcome at mid-term follow-upen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentİstinye Üniversitesi, Rektörlüken_US
dc.contributor.institutionauthorCarin, Mahmut Nezih
dc.identifier.volume35en_US
dc.identifier.issueSupplement: 3en_US
dc.identifier.startpage2103en_US
dc.identifier.endpage2103en_US
dc.relation.journalNEPHROLOGY DIALYSIS TRANSPLANTATIONen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record